Skip to content
10-Q/A

Quarterly Report

BIOETHICS, LTD.

0001096906-23-001174

← back to feed
Filed
May 23, 2023 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 19, 2023 1.14M sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$3.05K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$3.33K
Cash And Equivalents Q1 2023 · Mar 31, 2023 $250
Cash And Equivalents Q1 2023 · Dec 31, 2022 $295
Stockholders Equity Q1 2023 · Mar 31, 2023 −$702.75K
Stockholders Equity Q1 2023 · Dec 31, 2022 −$679.12K
Stockholders Equity Q1 2023 · Mar 31, 2022 −$607.59K
Stockholders Equity Q1 2023 · Dec 31, 2021 −$585.91K
Current Liabilities Q1 2023 · Mar 31, 2023 $703K
Current Liabilities Q1 2023 · Dec 31, 2022 $679.41K
Total Liabilities Q1 2023 · Mar 31, 2023 $703K
Total Liabilities Q1 2023 · Dec 31, 2022 $679.41K
Current Assets Q1 2023 · Mar 31, 2023 $250
Current Assets Q1 2023 · Dec 31, 2022 $295
Total Assets Q1 2023 · Mar 31, 2023 $250
Total Assets Q1 2023 · Dec 31, 2022 $295
Eps Basic Q1 2023 · Mar 31, 2023 −$0.02
Eps Basic Q1 2023 · Mar 31, 2022 −$0.02
Sga Expense Q1 2023 · Mar 31, 2023 $12.03K
Sga Expense Q1 2023 · Mar 31, 2022 $10.71K
Operating Income Q1 2023 · Mar 31, 2023 −$12.03K
Operating Income Q1 2023 · Mar 31, 2022 −$10.71K
Revenue Q1 2023 · Mar 31, 2023 $0
Revenue Q1 2023 · Mar 31, 2022 $0